Oct 28, 2025 | OC Business Journal

---

Member, Michael Demetriou, MD, PhD - Irvine Biotech Firm Pursues Cancer Cure

"It's the holy grail—one treatment to kill virtually all cancers"

Oct 28, 2025

---

Member, Min Zhang, MD, PhD - Anvil supports BigCARE 2025 Summer Workshop

"This year, Anvil made the implementation much smoother when we added some AI and machine learning tools for multi-omics data analysis."

Oct 28, 2025

---

Member, Matthew Landry, PhD, RDN - Love Green Tea? It Could Have Some Major Brain Benefits, According to New Research

A new study links this cozy beverage to slower brain aging and better focus.

Oct 28, 2025 | UC Irvine News

---

Member, Steve Goldstein, MD, PhD - UC Irvine Researchers Find New Alzheimer's Mechanism Linked to Brain Inflammation

Discovery reveals long-studied receptor is built differently than previously understood

Oct 27, 2025

---

Member, David Richardson, PhD - Nuclear Power Plant Workers Report Much Higher Rates of Common Cancers

“We wanted to strengthen the scientific basis for radiation protection by directly studying settings where low-dose exposures occur."

Oct 23, 2025

---

Member, Matthew Landry, PhD, RDN - Dietitians Warn of 12 Surprising Signs of Iron Deficiency

In severe cases, being low on iron may cause iron-deficiency anemia—when your red blood cells can’t carry enough oxygen because your body doesn’t have the iron it needs to build them properly.

Oct 23, 2025 | UC Irvine School of Medicine

---

Member, Munjal Acharya, PhD - UC Irvine Study Identifies a New Approach to Protect the Brain During Radiation Therapy

“This opens a realistic pathway to preserving quality of life for millions of brain cancer survivors currently facing this unmet medical need.”

Oct 23, 2025

---

Member, Matthew Landry, PhD, RDN - 6 Plant-Based Foods That Are Surprisingly High in Iron—No Beef Required

Switch up your iron intake with these plant-based options

Oct 17, 2025

---

Member, Michael Demetriou, MD, PhD - New Glycan-Based Diagnostic May Refine Cancer Detection and Treatment

GlyTR Therapeutics, co-founded by Demetriou and his former postdoctoral fellow Raymond W. Zhou, is advancing both the therapeutic and diagnostic platforms